blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0944388

EP0944388 - INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.02.2003
Database last updated on 31.08.2024
Most recent event   Tooltip28.02.2003Application deemed to be withdrawnpublished on 16.04.2003  [2003/16]
Applicant(s)For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
[N/P]
Former [1999/39]For all designated states
MERCK & CO., INC.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
Inventor(s)01 / ANTHONY, Neville, J.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
02 / DINSMORE, Christopher
126 East Lincoln Avenue
Rahway, NJ 07065 / US
03 / GOMEZ, Robert, P.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
04 / HUTCHINSON, John, H.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
05 / WAI, John, S.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
06 / WILLIAMS, Theresa, M.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
07 / BELL, Ian, M.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
08 / EMBREY, Mark, W.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
09 / FISHER, Thorsten, E.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[1999/39]
Representative(s)Thompson, John, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1999/39]Thompson, John Dr., et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date97921256.027.03.1997
[1999/39]
WO1997US06487
Priority number, dateUS19960014791P03.04.1996         Original published format: US 14791 P
GB1996000998113.05.1996         Original published format: GB 9609981
[1999/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9738665
Date:23.10.1997
Language:EN
[1997/45]
Type: A2 Application without search report 
No.:EP0944388
Date:29.09.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 23.10.1997 takes the place of the publication of the European patent application.
[1999/39]
Search report(s)International search report - published on:US27.11.1997
(Supplementary) European search report - dispatched on:EP28.06.2001
ClassificationIPC:A61K31/445, C07D401/04, C07D401/06, C07D401/12
[1999/39]
CPC:
C07D401/06 (EP); A61P13/12 (EP); A61P27/02 (EP);
A61P31/12 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P9/00 (EP); C07D211/62 (EP); C07D401/12 (EP);
C07D401/14 (EP); C07D413/14 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1999/39]
TitleGerman:HEMMERN VON FARNESYL PROTEIN TRANSFERASE[1999/39]
English:INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE[1999/39]
French:INHIBITEURS DE LA FARNESYL-PROTEINE TRANSFERASE[1999/39]
Entry into regional phase03.11.1998National basic fee paid 
03.11.1998Search fee paid 
03.11.1998Designation fee(s) paid 
03.11.1998Examination fee paid 
Examination procedure30.10.1997Request for preliminary examination filed
International Preliminary Examining Authority: US
03.11.1998Examination requested  [1999/39]
01.10.2002Application deemed to be withdrawn, date of legal effect  [2003/16]
05.11.2002Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2003/16]
Fees paidRenewal fee
31.03.1999Renewal fee patent year 03
31.03.2000Renewal fee patent year 04
02.04.2001Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.200206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PY]WO9610034  (MERCK & CO INC [US], et al) [PY] 1-25 * column W *;
 [PY]WO9630343  (MERCK & CO INC [US], et al) [PY] 1-25 * column W *;
 [PY]WO9609820  (MERCK & CO INC [US], et al) [PY] 1-25 * column W *;
 [PY]WO9637204  (MERCK & CO INC [US], et al) [PY] 1-25 * column W *;
 [A]WO9606609  (MERCK & CO INC [US], et al) [A] 1-25 * column W *;
 [A]WO9500497  (MERCK & CO INC [US], et al) [A] 1-25 * column W *;
 [A]EP0675112  (SQUIBB BRISTOL MYERS CO [US]) [A] 1-25 * column W *;
 [A]  - WILLIAMS,T. ET AL., "2-Substituted Piperazines as Constrained Amino Acids. Application to the Synthesis of Potent, Non Carboxylic Acid Inhibitors of Farnesyltransferase", J.MED.CHEM., WASHINGTON, (19960329), vol. 39, no. 7, pages 1345 - 1348, XP002169367 [A] 1-25 * column W *

DOI:   http://dx.doi.org/10.1021/jm9508090
 [A]  - GRAHAM,S.L., "Inhibitors of protein farnesylation : a new approach to cancer chemotherapy", EXP.OPIN.THER.PATENTS, LONDON, (1995), vol. 5, no. 12, pages 1269 - 1285, XP001000610 [A] 1-25 * column W *

DOI:   http://dx.doi.org/10.1517/13543776.5.12.1269
International search[XE]WO9718813  (MERCK & CO INC [US], et al);
 [XE]US5639775  (DURANT GRAHAM J [US], et al);
 [X]US5478934  (YUAN JUN [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.